Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Gliosarcoma 4Glioblastoma 4Uterine Cervical Neoplasms 3Vaginal Neoplasms 2Oligodendroglioma 2Glioma, Subependymal 2Glioma 2Ependymoma 2Carcinoma, Non-Small-Cell Lung 2Astrocytoma 2Skin Neoplasms 1Sarcoma, Ewing 1Prostatic Neoplasms 1Pinealoma 1Pancreatic Neoplasms 1Pancreatic Intraductal Neoplasms 1Neuroectodermal Tumors, Primitive 1Meningioma 1Medulloblastoma 1Lung Neoplasms 1Locally Advanced Cervical Adenocarcinoma 1Ganglioneuroblastoma 1Craniopharyngioma 1Choroid Plexus Neoplasms 1Carcinosarcoma 1Carcinoma, Endometrioid 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Vincristine 4X-Rays 3Phantoms, Imaging 3Magnetic Resonance Spectroscopy 3Doxorubicin 3Cyclophosphamide 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2ivosidenib 2cabozantinib 2Vemurafenib 2Specimen Handling 2Peripheral Blood Stem Cell Transplantation 2Nuclear Medicine Department, Hospital 2LY3023414 2Filgrastim 2Etoposide 2pegfilgrastim 1oncogene protein E7, Human papillomavirus type 16 1olaparib 1lexatumumab 1larotrectinib 1ganitumab 1fludarabine phosphate 1etoposide phosphate 1erdafitinib 1ensartinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Sarcoma, Ewing × Congresses as Topic × Clear all
NCT02306161 2026-06-03

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

National Cancer Institute (NCI)

Phase 3 Active not recruiting
312 enrolled 14 charts
Sarcoma

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡